Amino acid substitutions in LcrV at putative sites of interaction with toll-like receptor 2 do not affect the virulence of Yersinia pestis

Microbial Pathogenesis

Volumn 53, Issue 5-6, 2012, Pages 198-206

  Sun, Wei ^a   Curtiss, Roy ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

LcrV; Pathogenicity; Yersinia pestis

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; GLUTAMIC ACID; GLUTAMINE; INTERLEUKIN 10; INTERLEUKIN 8; LYSINE; PROTEIN LCRV; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM MUTANT; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; LCRV GENE; MOUSE; NONHUMAN; PATHOGENICITY; PLASMID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; TYPE III SECRETION SYSTEM; WILD TYPE; YERSINIA PESTIS;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, BACTERIAL; CELL LINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; MACROPHAGES; MICE; MUTANT PROTEINS; MUTATION, MISSENSE; PLAGUE; PORE FORMING CYTOTOXIC PROTEINS; PROTEIN BINDING; SURVIVAL ANALYSIS; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE; VIRULENCE FACTORS; YERSINIA PESTIS;

EID: 84867381234     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2012.07.003     Document Type: Article

References (49)

1. Perry R.D., Fetherston J.D. Yersinia pestis-etiologic agent of plague. Clinical Microbiology Reviews 1997, 10:35-66.
2. Cornelis G.R., Boland A., Boyd A.P., Geuijen C., Iriarte M., Neyt C., et al. The virulence plasmid of Yersinia, an antihost genome. Microbiology and Molecular Biology Reviews 1998, 62:1315-1352.
3. Cornelis G.R. Yersinia type III secretion send in the effectors. Journal of Cell Biology 2002, 158:401-408.
4. Burrows T.W. An antigen determining virulence in Pasteurella pestis. Nature 1956, 177:426-427.
5. Skryzpek E., Straley S.C. LcrG, a secreted protein involved in negative regulation of the low-calcium response in Yersinia pestis. Journal of Bacteriology 1993, 175:3520-3528.
6. Sarker M.R., Neyt C., Stainier I., Cornelis G.R. The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD. Journal of Bacteriology 1998, 180:1207-1214.
7. Motin V.L., Nakajima R., Smirnov G.B., Brubaker R.R. Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infection and Immunity 1994, 62:4192-4201.
8. Nedialkov Y.A., Motin V.L., Brubaker R.R. Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infection and Immunity 1997, 65:1196-1203.
9. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 2001, 19:683-765.
10. Sing A., Roggenkamp A., Geiger A.M., Heesemann J. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. Journal of Immunology 2002, 168:1315-1321.
11. Welkos S., Friedlander A., McDowell D., Weeks J., Tobery S. V antigen of Yersinia pestis inhibits neutrophil chemotaxis. Microbial Pathogenesis 1998, 24:185-196.
12. Nakajima R., Motin V.L., Brubaker R.R. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infection and Immunity 1995, 63:3021-3029.
13. Une T., Nakajima R., Brubaker R.R. Roles of V antigen in promoting virulence in Yersiniae. Contributions to Microbiology & Immunology 1987, 9:179-185.
14. Roggenkamp A., Geiger A.M., Leitritz L., Kessler A., Heesemann J. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infection and Immunity 1997, 65:446-451.
15. Sing A., Rost D., Tvardovskaia N., Roggenkamp A., Wiedemann A., Kirschning C.J., et al. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. The Journal of Experimental Medicine 2002, 196:1017-1024.
16. Reithmeier-Rost D., Bierschenk S., Filippova N., Schroder-Braunstein J., Sing A. Yersinia V antigen induces both TLR homo- and heterotolerance in an IL-10-involving manner. Cellular Immunology 2004, 231:63-74.
17. Overheim K.A., Depaolo R.W., Debord K.L., Morrin E.M., Anderson D.M., Green N.M., et al. LcrV plague vaccine with altered immunomodulatory properties. Infection and Immunity 2005, 73:5152-5159.
18. Sing A., Reithmeier-Rost D., Granfors K., Hill J., Roggenkamp A., Heesemann J. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proceedings of the Natural Academy of Sciences U S A 2005, 102:16,049-16,054.
19. Abramov V.M., Khlebnikov V.S., Vasiliev A.M., Kosarev I.V., Vasilenko R.N., Kulikova N.L., et al. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor. Journal of Proteome Research 2007, 6:2222-2231.
20. Depaolo R.W., Tang F., Kim I., Han M., Levin N., Ciletti N., et al. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host & Microbe 2008, 4:350-361.
21. Khan A.A., Babu J.P., Gupta G., Rao D.N. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis. Vaccine 2008, 26:316-332.
22. Pouliot K., Pan N., Wang S., Lu S., Lien E., Goguen J.D. Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis. Infection and Immunity 2007, 75:3571-3580.
23. Reithmeier-Rost D., Hill J., Elvin S.J., Williamson D., Dittmann S., Schmid A., et al. The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis. Microbes and Infection 2007, 9:997-1002.
24. Gong S., Bearden S.W., Geoffroy V.A., Fetherston J.D., Perry R.D. Characterization of the Yersinia pestis Yfu ABC inorganic iron transport system. Infection and Immunity 2001, 69:2829-2837.
25. Bertani G. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. Journal of Bacteriology 1951, 62:293-300.
26. 2+ in Yersinia pestis include structural genes for outer membrane proteins. Infection and Immunity 1986, 51:445-454.
27. Sun W., Wang S., Curtiss R. Highly efficient method for introducing successive multiple scarless gene deletions and markerless gene insertions into the Yersinia pestis chromosome. Applied and Environmental Microbiology 2008, 74:4241-4245.
28. Sun W., Roland K.L., Branger C.G., Kuang X., Curtiss R. The role of relA and spoT in Yersinia pestis KIM5+ pathogenicity. PLoS One 2009, 4:e6720.
29. Lecoeur H. Nuclear apoptosis detection by flow cytometry: influence of endogenous endonucleases. Experimental Cell Research 2002, 277:1-14.
30. Hirschfeld M., Ma Y., Weis J.H., Vogel S.N., Weis J.J. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. Journal of Immunology 2000, 165:618-622.
31. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. American Journal of Hygiene 1938, 27:493-497.
32. 2+ response, and virulence of Yersinia pestis. Journal of Bacteriology 1995, 177:2530-2542.
33. Monack D.M., Mecsas J., Ghori N., Falkow S. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proceedings of Natural Academy of Sciences USA 1997, 94:10385-10390.
34. Applequist S.E., Wallin R.P., Ljunggren H.G. Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. International Immunology 2002, 14:1065-1074.
35. Une T., Brubaker R.R. In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae. Infection and Immunity 1984, 43:895-900.
36. Sun W., Six D., Kuang X.Y., Roland K.L., Raetz C.R.H., Curtiss R. A live attenuated strain of Yersinia pestis KIM as a vaccine against plague. Vaccine 2011, 29:2986-2998.
37. Agar S.L., Sha J., Foltz S.M., Erova T.E., Walberg K.G., Parham T.E., et al. Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92. Microbiology 2008, 154:1939-1948.
38. Lathem W.W., Crosby S.D., Miller V.L., Goldman W.E. Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proceedings of Natural Academy of Sciences USA 2005, 102:17786-17791.
39. Foligne B., Dessein R., Marceau M., Poiret S., Chamaillard M., Pot B., et al. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Gastroenterology 2007, 133:862-874.
40. Branger C.G., Sun W., Torres-Escobar A., Perry R., Roland K.L., Fetherston J., et al. Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge. Vaccine 2010, 29:274-282.
41. Auerbuch V., Isberg R.R. Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10. Infection and Immunity 2007, 75:3561-3570.
42. Philipovskiy A.V., Cowan C., Wulff-Strobel C.R., Burnett S.H., Kerschen E.J., Cohen D.A., et al. Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis. Infection and Immunity 2005, 73:1532-1542.
43. Kang J.Y., Nan X., Jin M.S., Youn S.J., Ryu Y.H., Mah S., et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009, 31:873-884.
44. Kovacs-Simon A., Titball R.W., Michell S.L. Lipoproteins of bacterial pathogens. Infection and Immunity 2011, 79:548-561.
45. Giambartolomei G.H., Dennis V.A., Lasater B.L., Philipp M.T. Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infection and Immunity 1999, 67:140-147.
46. Lemaitre N., Sebbane F., Long D., Hinnebusch B.J. Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague. Infection and Immunity 2006, 74:5126-5131.
47. Fetherston J.D., Schuetze P., Perry R.D. Loss of the pigmentation phenotype in Yersinia pestis is due to the spontaneous deletion of 102 kb of chromosomal DNA which is flanked by a repetitive element. Molecular Microbiology 1992, 6:2693-2704.
48. Sikkema D.J., Brubaker R.R. Resistance to pesticin, storage of iron, and invasion of HeLa cells by Yersiniae. Infection and Immunity 1987, 55:572-578.
49. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proceedings of Natural Academy of Sciences USA 2000, 97:6640-6645.